Cyclo Therapeutics, Inc. Alternatives & Competitors

12 companies similar to Cyclo Therapeutics, Inc. — Dedicated to developing life-changing medicines for patients and families living...

Scioderm, Inc., an Amicus Therapeutics Company

Dedicated to pioneering topical solutions for treating chronic skin diseases.

2 Series B $37.00M

Durham, United States

Biotechnology Health Care +1

Santhera Pharmaceuticals

We are dedicated to developing medicines to meet the needs of patients living with rare di...

93 Post-IPO Debt $246.54M

Pratteln, Switzerland

Biotechnology Health Care +1

Chemomab Therapeutics

Developing innovative therapeutics for diseases at confluence of fibrosis and inflammation...

21 Post-IPO Equity $90.50M

Israel

Biotechnology Health Care +1

Ocelot Bio

Developing innovative therapeutics to significantly improve outcomes for patients with end...

4 Debt Financing

Redwood City, United Stat...

Biotechnology Health Care +1

Rival Readout

Competing with Cyclo Therapeutics, Inc.? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout

Synlogic

Designed for Life

20 IPO $422.40M

Cambridge, United States

Biotechnology Health Care +1

Circio Holding ASA

Developing novel circular RNA and immunotherapy medicines.

20 Post-IPO Debt $262.30M

Oslo, Norway

Biotechnology Health Care

Rivus Pharmaceuticals

Developing new oral medicines to advance cardiometabolic health

29 Series B $167.00M

Charlottesville, United S...

Biotechnology Health Care +1

Accure Therapeutics

R&D pharma dedicated to developing innovative medicines to treat patients suffering from C...

12 Grant $9.20M

Barcelona, Spain

Biotechnology Health Care +1

InflaRx

Controlling Inflammation - developing drugs to treat life threatening and chronic inflamma...

46 Post-IPO Equity $250.20M

Jena, Germany

Health Care Health and Wellness +1

Quince Therapeutics

Dedicated to unlocking the power of a patient’s own biology for the treatment of rare dise...

25 Post-IPO Equity

South San Francisco, Unit...

Biotechnology Health Care +1

Palatin Technologies

We discover and develop novel therapeutics for patients living with inflammatory and autoi...

50 Post-IPO Equity $133.90M

Biotechnology Health Care +1

Forma Therapeutics

Dedicated to transforming the lives of patients with rare hematologic diseases and cancers...

159 Series D $142.50M

Watertown, United States

Biotechnology Health Care +1

Frequently Asked Questions

Companies similar to Cyclo Therapeutics, Inc. include Scioderm, Inc., an Amicus Therapeutics Company, Santhera Pharmaceuticals, Chemomab Therapeutics, Ocelot Bio, Synlogic. They work in Biotechnology and Health Care.

Bounce Watch lists 12 companies that share Cyclo Therapeutics, Inc.'s industries and are closest to it in business tags, services, target customers, business model and size.

Cyclo Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing life-changing medicines for patients and families living with challenging diseases. The company's Trappsol® Cyclo™ is an orphan drug designated product in the United States and Europe, and is the subject of four formal clinical t...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Cyclo Therapeutics, Inc.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Book a 7-day Readout Get a free snapshot

Explore Related

Cyclo Therapeutics, Inc. Profile Scioderm, Inc., an Amicus Therapeutics Company Alternatives Santhera Pharmaceuticals Alternatives Chemomab Therapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. The 11 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.